The WellBN Question: Law, Consent, and the Medicalisation of Minors in the NHS
A High Court challenge exposes the fault lines between clinical autonomy, national safeguards, and the limits of consent in contemporary British medicine
The proceedings in ATN v WellBN Partnership, now before the High Court in London, are not merely a dispute about a single GP practice. They represent a test case for the integrity of the National Health Service’s governance framework and the rule of law itself. At stake is a question both precise and profound: whether NHS-contracted general practitioners may lawfully prescribe cross-sex hormones to minors outside national policy constraints, and, if they cannot, why such practices were permitted to persist at all.
The facts, as advanced at the permission hearing before Mr Justice MacDonald, are stark. The claimant, a father identified as ATN, alleges that his child was prescribed gender-affirming hormones by the WellBN Partnership—a GP provider operating in Brighton—without parental consent and in a manner inconsistent with NHS guidance. Counsel for the claimant, Vikram Sachdeva KC, argued that the practice adopted an “informed consent” model which, in practical terms, required little more than a baseline blood test, a single consultation of approximately forty minutes, and the signing of a consent form before prescribing commenced.
This model, it is alleged, was deployed in respect of dozens of patients. Evidence placed before the court indicated that approximately seventy under-18s were included in a subsequent NHS-commissioned safety review into the practice’s prescribing. More significantly still, NHS England is said to have informed the partnership in terms that admit of little ambiguity that it had “no lawful basis for providing NHS-funded treatment of this kind”, warning that continuation could result in termination of its NHS agreement.
The defendant’s position is equally clear. Represented by Nicola Newbegin KC, the partnership contends that the claim is now devoid of merit. The prescribing in question has ceased; the policy has been withdrawn; the practice is compliant with NHS direction. Whatever dispute may once have existed, it is said to be historical, academic, and more properly the domain of regulators or contractual adjudication rather than public law. The Administrative Court, in this view, is not the proper forum for resolving contested questions of medical policy.
Judicial Review and the Limits of the Court
At the heart of the hearing lies the doctrine of judicial restraint. Judicial review is not an instrument for the resolution of generalised disputes or academic disagreements. The principle articulated in R v Secretary of State for the Home Department, ex parte Salem establishes that courts should decline to hear cases which no longer present a live controversy between the parties unless a discrete point of public importance requires determination.¹
The defendant relies heavily upon this principle. The policy has ended; the claimant’s child is approaching adulthood; there is no ongoing treatment to restrain. To proceed, it is argued, would be to transform the court into a supervisory body over medical debate itself.
Yet the claimant’s case is framed at a different level. The issue is not merely what WellBN did, but what it asserted it was entitled to do. The partnership’s correspondence with NHS England, placed before the court, is said to maintain that such prescribing fell within the scope of “essential services” under the GMS contract. That position, it is argued, has never been withdrawn in substance, even if the practice has ceased the conduct in question.
The distinction is critical. If a GP practice may lawfully interpret its contractual obligations so as to include the prescription of cross-sex hormones to minors without specialist oversight, then the potential for replication elsewhere is obvious. The claim, therefore, is not academic but preventative—seeking clarification of the legal boundary before it is crossed again.
Public Function and the Nature of GP Authority
The defendant’s argument that a GP partnership is not amenable to judicial review because it is, in law, a private entity sits uneasily with the constitutional reality of the NHS. General practitioners operate within a statutory framework, exercising delegated authority over access to publicly funded healthcare. They are not merely service providers; they are gatekeepers.
The courts have long recognised, particularly since R v Panel on Take-overs and Mergers, ex parte Datafin plc, that the distinction between public and private bodies is not determined solely by formal status but by the nature of the function performed.² Where a body exercises power with public consequences, derived from a statutory scheme, it may be subject to public law duties regardless of its corporate form.
Applied to the present case, the argument is straightforward. A GP practice prescribing medication under NHS funding, within a nationally regulated framework, is performing a public function. To suggest otherwise is to reduce the NHS to a patchwork of private actors, exercising public power without public accountability—an arrangement as unstable in law as it would be intolerable in practice.
Essential Services or Specialised Care?
The substantive legal dispute turns on the interpretation of the General Medical Services contract. Under this framework, GP practices are required to provide “essential services” relating to the management of illness and the provision of necessary treatment. More specialised interventions, however, fall within the domain of secondary or tertiary care, commissioned centrally by NHS England.
The claimant’s case is that the prescription of cross-sex hormones to minors falls squarely within this specialised category. It is a treatment requiring multidisciplinary assessment, psychological evaluation, and long-term monitoring—precisely the sort of intervention that national policy has increasingly sought to restrict to specialist services.
This position is reinforced by the findings of the 2024 review led by Hilary Cass, which concluded that the evidence base for such interventions in children and adolescents was “remarkably weak” and recommended that hormone treatment should be approached with “extreme caution.”³ The review emphasised the need for a structured, research-led framework rather than ad hoc clinical decision-making in primary care.
In response to these findings, NHS England implemented a policy effectively pausing routine access to gender-affirming hormones for under-18s outside controlled settings.⁴ It is against this backdrop that WellBN’s alleged continuation of prescribing—on an informed consent basis—becomes not merely controversial, but prima facie incompatible with the direction of national clinical governance.
If such treatment lies outside the scope of essential services, then its provision under a GMS contract would not merely be clinically questionable; it would be unlawful.
Consent, Competence, and the Fragility of Autonomy
The defendant places significant reliance on the age and competence of the patient. At sixteen, a young person is presumed capable of consenting to medical treatment, subject to the principles established in Gillick v West Norfolk and Wisbech Area Health Authority.⁵
Yet the application of Gillick competence in the context of gender medicine has been the subject of intense judicial and medical scrutiny. In Bell v Tavistock, the Divisional Court questioned whether adolescents could fully understand the long-term implications of puberty blockers and subsequent hormone treatment, noting the experimental nature of the evidence base.⁶ Although the Court of Appeal later restored clinical discretion, the underlying concern—that consent may be formally valid yet substantively fragile—has never been resolved, only deferred.
The present case introduces an additional dimension: parental exclusion. While the law does not grant parents an absolute right to override a competent minor’s decision, the effective marginalisation of parental involvement in cases involving life-altering medical interventions raises serious safeguarding concerns. It suggests a model of care in which autonomy is treated as absolute, even where the consequences are profound, uncertain, and irreversible.
Institutional Tension and the Brighton Context
The significance of this case is amplified by its setting. Brighton has long functioned as a cultural and institutional vanguard—a city whose public bodies and professional practices have often moved ahead of national settlement, particularly in areas touching upon identity, social policy, and healthcare provision. The WellBN model, as described in court, appears to reflect precisely such a trajectory: locally embedded, ideologically confident, and operationally permissive.
This is not, in itself, unlawful. But when such an ethos collides with national policy, the result is not innovation but fracture. The intervention of NHS England—culminating in the warning that there existed “no lawful basis” for the prescribing—suggests that this fracture had already widened into open contradiction.
More troubling is the implication that the practice continued until compelled to stop. If accurate, this raises questions not merely about one provider, but about the responsiveness of the system tasked with oversight. Why was enforcement reactive rather than preventative? Why did it require the pressure of litigation to achieve compliance? And how many similar practices may have operated unexamined beyond the reach of scrutiny?
Beyond the Immediate Case
The court’s decision at the permission stage will determine whether these questions receive judicial examination. If permission is refused, the matter will likely revert to regulators and policymakers. If granted, it will open the door to a substantive hearing capable of clarifying the legal limits of GP authority in one of the most contested areas of modern medicine.
Yet regardless of the outcome, the underlying issues will persist. The tension between local clinical autonomy and national governance is structural, not incidental. So too is the challenge of balancing patient autonomy with safeguarding in cases involving vulnerable adolescents navigating complex and often unstable identities.
What the WellBN case reveals, above all, is a system that has permitted practice to run ahead of proof, and ideology to outrun evidence. The rapid evolution of gender medicine has exposed regulatory gaps, evidential weaknesses, and institutional hesitations—gaps within which contested models of care have taken root.
Conclusion: The Recovery of Limits
In the final analysis, this case is about the recovery of limits. It confronts the assumption that consent, once obtained, is sufficient to legitimise any form of medical intervention, irrespective of its evidential foundation or its long-term consequences. It challenges the notion that decentralised clinical judgment can operate independently of national standards in areas marked by profound uncertainty.
Most fundamentally, it asks whether a society still possesses the moral and legal coherence to protect the vulnerable when doing so requires restraint rather than affirmation. The language of autonomy, powerful though it is, cannot carry this burden alone. It must be bounded by prudence, disciplined by evidence, and ordered toward the good of the person as a whole.
The courts cannot resolve every dimension of this dispute. But they can insist upon this: that power exercised in the name of care must remain accountable to law, to reason, and to reality itself.
For when medicine abandons its limits, it does not expand freedom—it endangers those it was first called to protect.
¹ R v Secretary of State for the Home Department, ex parte Salem [1999] 1 AC 450 (HL).
² R v Panel on Take-overs and Mergers, ex parte Datafin plc [1987] QB 815 (CA).
³ Cass Review, Final Report (2024), findings on evidential limitations and clinical caution.
⁴ NHS England, Clinical Commissioning Policy: Prescribing of Gender-Affirming Hormones (2024; updated 2025 pause on routine prescribing for under-18s).
⁵ Gillick v West Norfolk and Wisbech Area Health Authority [1986] AC 112.
⁶ Bell v Tavistock and Portman NHS Foundation Trust [2020] EWHC 3274 (Admin); [2021] EWCA Civ 1363.
RELATED ARTiCLES
LATEST ARTICLES
- Today’s Mass: August 01 S. Peter ad VinculaToday is the Feast of Saint Peter’s Chains. The chains with which Peter the Apostle was fettered from time to time have always been the object of veneration among the faithful. They are preserved in a basilica in Rome, which is called Saint Peter ad Vincula (in chains).
- 02.08.26 Nuntiatoria CXVII: Res Sunt Quod SuntNuntiatoria CXVII explores various conflicts arising from the tension between institutional narratives and reality, including issues related to the traditional Roman Mass, women’s ordination, and synodality. The edition argues for the importance of recognising clear distinctions in these matters, emphasising that reality cannot be altered by institutional preference.
- Ordo w/c 02.08.26The content outlines the liturgical celebrations and saints commemorated from August 2nd to August 9th, including their corresponding Mass colors and types. It specifies the calendar dates, feasts of saints, and mentions various permissible votive Masses.
- The Publican’s Prayer and the Order of Grace: The Tenth Sunday after PentecostThe Mass of the Tenth Sunday after Pentecost emphasises humility as essential in the relationship between humanity and God. By contrasting the Pharisee and the publican, it illustrates that true justification comes from recognising one’s sinfulness and reliance on divine mercy rather than self-righteousness. Humility leads to a deeper faith and cooperation with grace.
- Archbishop Wester, the Albuquerque Mosque and the One-Way Doctrine of Religious LibertyArchbishop John Wester’s support for a mosque in Albuquerque raises concerns about equating civic duty with moral obligation, particularly as it overlooks Christian persecution in Muslim-majority countries. While advocating for Muslim rights, he fails to address the need for reciprocal support for Christians, leading to an incomplete dialogue on religious liberties.
CURRENT EDITION
DAILY MASS ONLINE
One of the earliest online apostolates dedicated to the Traditional Latin Mass, Old Roman TV began broadcasting the Holy Sacrifice on the Feast of the Assumption, 15 August 2008. During the COVID-19 pandemic, additional programming — devotions, catechesis, and conferences — was added to support the faithful in prayer and formation.
Support the daily Holy Mass on Old Roman TV by offering a Mass intention — for loved ones, thanksgiving, or the repose of souls. Your intention helps sustain the sacred liturgy and brings grace to those you remember before God’s altar.
SUPPORT THE DAILY MASS ONLINE
Likely the world’s longest-running daily online broadcast of the
Traditional Latin Mass, streaming faithfully since the
Feast of the Assumption 2008.
This apostolate cannot continue without immediate help
Please support us with a contribution toward
chapel rent, sacristy supplies, operating costs, and web-hosting.
Our essential monthly costs reach £1,000.
MASS INTENTIONS
If your offering is for a Mass Intention, kindly complete the form below in full so we may correctly match it to your donation. For anniversary intentions — birthdays, wedding anniversaries, anniversaries of death — please be sure to include the relevant date.
Today’s Mass Propers
- Today’s Mass: August 01 S. Peter ad Vincula
Today is the Feast of Saint Peter’s Chains. The chains with which Peter the Apostle was fettered from time to time have always been the object of veneration among the faithful. They are preserved in a basilica in Rome, which is called Saint Peter ad Vincula (in chains).
Leave a Reply